Targeting colorectal cancer with human anti-EGFR monoclonocal antibodies: focus on panitumumab

Overview of attention for article published in Biologics: Targets & Therapy, June 2008

Altmetric Badge

Mentioned by

patent: 6 patents

Citations

dimensions_citation: 40 Dimensions

Readers on

mendeley: 47 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 6 patents that reference this research output.

Binding molecules that inhibit cancer growth

Grant US-11939394-B2

United States of America

Methods of treating a subject having an EGFR-positive and/or ErbB-3-positive tumor

Grant US-11820825-B2

United States of America

ErbB-2 and ErbB3 binding bispecific antibodies for use in the treatment of cells that…

Grant US-11780925-B2

United States of America

Antibodies that bind EGFR and cMET

Grant US-11773170-B2

United States of America

Combination products with tyrosine kinase inhibitors and their use

Grant US-11096947-B2

United States of America

Anti-EGFR antibody and anti-c-Met/anti-EGFR bispecific antibodies comprising the same

Grant US-9902776-B2

United States of America